topicChromium Metabolic Markers Randomized Trial
claimEarly experimental studies suggest that chromium supplementation may enhance insulin action, including modulation of IRS-mediated PI3K/Akt signaling and increased GLUT4 expression, thereby promoting glucose uptake in insulin-sensitive tissues, although these effects appear to be model-dependent [–].
evidence level3
citationTuzcu Mehmet (2026)
sourceChromium(III) Beyond Insulin: A Mechanistic Roadmap Across the Energy–Redox–Inflammation Triad in Obesity and Cardiometabolic Disease
topicChromium Metabolic Markers Randomized Trial
claimIn controlled low-chromium diets, chromium supplementation improved glucose, insulin, and glucagon responses following OGTT in subjects with impaired glucose handling, whereas metabolically healthy individuals showed minimal or no response.
evidence level3
citationTuzcu Mehmet (2026)
sourceChromium(III) Beyond Insulin: A Mechanistic Roadmap Across the Energy–Redox–Inflammation Triad in Obesity and Cardiometabolic Disease
topicChromium Metabolic Markers Randomized Trial
claimSubsequent reviews by Mertz further emphasized that chromium-responsive phenotypes are typically associated with disturbed metabolic states, including insulin resistance, malnutrition, or stress-related metabolic dysfunction [].
evidence level3
citationTuzcu Mehmet (2026)
sourceChromium(III) Beyond Insulin: A Mechanistic Roadmap Across the Energy–Redox–Inflammation Triad in Obesity and Cardiometabolic Disease
topicChromium Metabolic Markers Randomized Trial
claim1 3 2 4 6 7 10 11 12 13 Obesity is increasingly recognized as a complex systemic disorder characterized by mitochondrial dysfunction, impaired cellular energy sensing, oxidative stress, and chronic low-grade inflammation, rather than a passive consequence of excess energy intake [–].
evidence level3
citationTuzcu Mehmet (2026)
sourceChromium(III) Beyond Insulin: A Mechanistic Roadmap Across the Energy–Redox–Inflammation Triad in Obesity and Cardiometabolic Disease